A Non-Hallucinogenic LSD Analog With Therapeutic Potential for Mood Disorders

被引：0
|
作者：
Valles, Argel Aguilar [1 ]
Lewis, Vern [1 ]
Telfer, Andre [1 ]
Arsenault, Emily [1 ]
Taghavi-Abkuh, Fatimeh-Frouh [1 ]
El Sayegh, Fatema [1 ]
Abizaid, Alfonso [1 ]
机构：
[1] Carleton Univ, Ottawa, ON, Canada
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷
关键词：
LSD; Dendritic Arborization; Spine Morphogenesis; Stress Coping; 5-HT2A Receptor;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P358
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [31] Therapeutic Potential of 5-HT7 Receptors in Mood Disorders
    Mnie-Filali, Ouissame
    Lambas-Senas, Laura
    Scarna, Helene
    Haddjeri, Nasser
    CURRENT DRUG TARGETS, 2009, 10 (11) : 1109 - 1117
  • [32] Cannabinoids in the therapeutic management of mood disorders
    Vasile, Daniel
    Vasiliu, Octavian
    Mangalagiu, Andrei Gabriel
    Petrescu, Bogdan Mircea
    Candea, Cristian Alexandru
    Tudor, Corina
    Bratu-Bizic, Roxana Elena
    Fainarea, Andreea Filareta
    Patrascu, Mihaela Cristina
    BIPOLAR DISORDERS, 2023, 25 : 83 - 83
  • [33] New Therapeutic Strategy for Mood Disorders
    Crupi, R.
    Marino, A.
    Cuzzocrea, S.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (28) : 4284 - 4298
  • [34] New Therapeutic Targets for Mood Disorders
    Machado-Vieira, Rodrigo
    Salvadore, Giacomo
    DiazGranados, Nancy
    Ibrahim, Lobna
    Latov, David
    Wheeler-Castillo, Cristina
    Baumann, Jacqueline
    Henter, Ioline D.
    Zarate, Carlos A., Jr.
    THESCIENTIFICWORLDJOURNAL, 2010, 10 : 713 - 726
  • [35] LSD 1 is a Potential Therapeutic Target in Medulloblastoma
    Pajtler, K.
    Thor, T.
    Oles, L.
    Baumann, M.
    Heukamp, L. C.
    Buettner, R.
    Kirjel, J.
    Schramm, A.
    Eggert, A.
    Schulte, J.
    KLINISCHE PADIATRIE, 2009, 221 (03): : 203 - 204
  • [36] Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia
    Choi, Jinyoung
    Kang, Jiseung
    Kim, Tae
    Nehs, Christa J.
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [37] Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities
    Pfau, Madeline L.
    Menard, Caroline
    Russo, Scott J.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 411 - 428
  • [38] New Therapeutic Options for Anxiety and Mood Disorders
    Nardi, Antonio Egidio
    Machado, Sergio
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (06) : 927 - 929
  • [39] Allopregnanolone in mood disorders: Mechanism and therapeutic development
    Chen, Shiyi
    Gao, Lijuan
    Li, Xiaoyu
    Ye, Yiping
    PHARMACOLOGICAL RESEARCH, 2021, 169
  • [40] Nicotine as therapeutic agent in treatment of mood disorders
    Tsopelas, C.
    Petros, N.
    Maria, D.
    Dimitris, P.
    Angelica, G. G.
    Dimitra, K.
    Charalampos, T.
    EUROPEAN PSYCHIATRY, 2016, 33 : S552 - S552
12345